BioXcel Therapeutics, Inc.BTAI

Market cap

$10.9M

P/E ratio

	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	43	32	213	233	194	65	30
Accounts receivable, net	-	-	-	-	0	0	0
Inventory	-	-	-	-	2	2	1
Prepaid expenses	0	2	4	3	3	3	5
Other current assets	-	-	-	1	4	2	1
Total current assets	43	34	217	237	203	72	37
Property and equipment, net	0	1	1	1	1	1	0
Operating lease right-of-use assets	-	1	2	1	1	1	0
Other assets	0	0	0	0	1	0	0
Total assets	44	36	220	239	206	74	38
Accounts payable	2	5	4	5	10	14	16
Accrued expenses	3	3	7	11	19	12	6
Accrued interest	-	-	-	-	3	1	-
Related Party	-	-	-	-	-	0	0
Nonrelated Party	-	-	-	-	-	0	0
Other current liabilities	-	0	0	0	0	-	-
Total current liabilities	5	8	12	17	33	27	22
Operating Lease, Liability, Noncurrent	-	1	1	1	1	0	0
Derivative liabilities	-	-	-	-	2	2	7
Long-term debt	-	-	-	-	93	101	103
Total liabilities	5	9	13	18	129	130	131
Common Stock, Value, Issued	0	0	0	0	0	0	0
Additional paid-in-capital	63	84	346	467	488	534	557
Accumulated deficit	-24	-57	-139	-246	-412	-591	-650
Total stockholders' (deficit) equity	39	27	207	222	77	-57	-93
Total liabilities and stockholders' (deficit) equity	44	36	220	239	206	74	38